Financhill
Sell
16

ANAB Quote, Financials, Valuation and Earnings

Last price:
$14.55
Seasonality move :
-2.76%
Day range:
$14.20 - $15.29
52-week range:
$14.20 - $41.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.95x
P/B ratio:
5.23x
Volume:
1.6M
Avg. volume:
686.3K
1-year change:
-25.68%
Market cap:
$441.2M
Revenue:
$17.2M
EPS (TTM):
-$6.08

Earnings Data

Next earnings date for ANAB
Mar 11
2025
Most recent earnings per share
-$1.14
Beat by $0.47
(Nov 5/2024)
Consensus Estimate
-$1.61
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ANAB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/11/2025 Q4 $7.8M -- -- -$1.70 --
11/05/2024 Q3 $8.2M $30M -$1.14 -$1.61 $0.47
08/05/2024 Q2 $22.8M $11M -$1.71 -$0.93 -$0.78
05/09/2024 Q1 $4M $7.2M -$1.64 -$1.60 -$0.04
03/11/2024 Q4 $3.7M $9M -$1.59 -$1.50 -$0.10
11/02/2023 Q3 -- -- -$1.41 -$1.89 $0.48
08/07/2023 Q2 -- -- -$1.50 -$1.74 $0.24
05/11/2023 Q1 -- -- -$1.58 -$1.02 -$0.56
03/01/2023 Q4 -- -- -$0.93 -$0.94 $0.01
11/08/2022 Q3 -- -- -$1.18 -$0.63 -$0.55
08/08/2022 Q2 -- -- -$1.15 -$1.07 -$0.08
05/04/2022 Q1 -- -- -$1.31 -$1.01 -$0.30
03/07/2022 Q4 -- -- -$1.18 $3.99 -$5.17
11/04/2021 Q3 -- -- -$0.24 -$0.98 $0.74
08/09/2021 Q2 -- -- -$0.02 -$0.03 $0.01
05/04/2021 Q1 -- -- -$0.66 -$0.83 $0.17
02/25/2021 Q4 -- -- $1.23 $0.60 $0.63
11/04/2020 Q3 -- -- -$0.87 -$0.69 -$0.18
08/10/2020 Q2 -- -- -$0.79 -$0.65 -$0.14
05/06/2020 Q1 -- -- -$0.30 -$0.80 $0.50
03/02/2020 Q4 -- -- -$0.75 -$1.28 $0.53
11/08/2019 Q3 -- -- -$1.15 -$1.14 -$0.01
08/08/2019 Q2 -- -- -$0.89 -$0.95 $0.06
05/07/2019 Q1 -- -- -$0.82 -$0.78 -$0.04
02/28/2019 Q4 -- -- -$0.64 -$0.86 $0.22
11/08/2018 Q3 -- -- -$0.66 -$0.70 $0.04
08/07/2018 Q2 -- -- -$0.57 -$0.67 $0.10
05/08/2018 Q1 -- -- -$0.63 -$0.46 -$0.17
03/05/2018 Q4 -- -- -$0.30 -$0.42 $0.12
11/07/2017 Q3 -- -- -$0.45 -$0.47 $0.02
08/10/2017 Q2 -- -- -$0.13 -$0.42 $0.29
05/11/2017 Q1 -- -- -$0.75 -$0.18 -$0.57

AnaptysBio Earnings Questions

  • How Much did AnaptysBio Generate in Revenue Last Quarter?

    AnaptysBio reported $30M worth of top line sales in its most recent quarter.

  • Did AnaptysBio Beat Earnings Last Quarter?

    AnaptysBio announced earnings per share of -$1.14 which represents a beat of analyst forecast a -$1.61 per share.

  • Is AnaptysBio Profitable?

    AnaptysBio reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for AnaptysBio EPS Next Year?

    AnaptysBio's earnings are forecast to decrease from -$6.08 per share to -$5.98 per share next year representing a decrease of -2.39%.

  • When is AnaptysBio's Earnings Date?

    AnaptysBio's next earnings date is March 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock